Human ACE2 Protein
$350.00 – $1,500.00
| Protein Name | Recombinant Human ACE2 Protein |
| Catalog Number | 19CoV-A10019CoV-A100 |
| Alternative Name | Angiotensin-converting enzyme 2, hACE2 |
| Purity | 95% or above |
| Protein Construction | Human ACE2 protein containing Gln18-Asp615 (Accession # Q9BYF1-1) C-terminal fusion with rabbit IgG Fc |
| Endotoxin | <0.1 EU per ug of protein as determined by LAL method |
| Origin Species | Homo sapiens (Human) |
| Expression Host | HEK293F |
| Protein type | Recombinant |
| Purification tag | C-terminal rabbit IgG Fc. Protein A column purified |
| Molecule Mass | Predicted molecular weight 194 kD |
| Regulation restrictions | For research use only |
| Shipping | Recombinant proteins are provided as frozen liquid and will be shipped out with dry ice. |
| Stability and storage | The protein is stable in a liquid state at -70℃ for 12 months. Avoid repeated freeze-thaw cycles. |
Additional information
| Size | 100µg, 1mg |
|---|
Background information
The protein encoded by this gene belongs to the angiotensin-converting enzyme family of dipeptidyl carboxydipeptidases and has considerable homology to human angiotensin 1 converting enzyme. This secreted protein catalyzes the cleavage of angiotensin I into angiotensin 1-9, and angiotensin II into the vasodilator angiotensin 1-7. ACE2 is known to be expressed in various human organs, and its organ- and cell-specific expression suggests that it may play a role in the regulation of cardiovascular and renal function, as well as fertility. In addition, the encoded protein is a functional receptor for the spike glycoprotein of the human coronavirus HCoV-NL63 and the human severe acute respiratory syndrome coronaviruses, SARS-CoV and SARS-CoV-2, the latter is the causative agent of coronavirus disease-2019 (COVID-19). Multiple splice variants have been found for this gene and the dACE2 (or MIRb-ACE2) splice variant has been found to be interferon inducible.
Reviews
There are no reviews yet.